
Urinary Retention Drug Global Market Report 2025
Description
Urinary Retention Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urinary retention drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for urinary retention drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urinary retention drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Drug Class: Alpha Blockers; Beta-3 Agonists; Anticholinergics; Surgical Agents
2) By Indication: Chronic Urinary Retention; Postoperative Urinary Retention; Neurogenic Bladder
3) By Administration: Oral; Injectable; Transdermal
4) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Alpha Blockers: Alpha-1 Blockers; Alpha-2 Blockers
2) By Beta-3 Agonists: Selective Beta-3 Agonists
3) By Anticholinergics: Antimuscarinics; Non-Selective Anticholinergics
4) By Surgical Agents: Anesthetics; Hemostatic Agents; Muscle Relaxants; Antibiotic Prophylaxis
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on urinary retention drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for urinary retention drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urinary retention drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Drug Class: Alpha Blockers; Beta-3 Agonists; Anticholinergics; Surgical Agents
2) By Indication: Chronic Urinary Retention; Postoperative Urinary Retention; Neurogenic Bladder
3) By Administration: Oral; Injectable; Transdermal
4) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Alpha Blockers: Alpha-1 Blockers; Alpha-2 Blockers
2) By Beta-3 Agonists: Selective Beta-3 Agonists
3) By Anticholinergics: Antimuscarinics; Non-Selective Anticholinergics
4) By Surgical Agents: Anesthetics; Hemostatic Agents; Muscle Relaxants; Antibiotic Prophylaxis
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Urinary Retention Drug Market Characteristics
- 3. Urinary Retention Drug Market Trends And Strategies
- 4. Urinary Retention Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Urinary Retention Drug Growth Analysis And Strategic Analysis Framework
- 5.1. Global Urinary Retention Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Urinary Retention Drug Market Growth Rate Analysis
- 5.4. Global Urinary Retention Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Urinary Retention Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Urinary Retention Drug Total Addressable Market (TAM)
- 6. Urinary Retention Drug Market Segmentation
- 6.1. Global Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alpha Blockers
- Beta-3 Agonists
- Anticholinergics
- Surgical Agents
- 6.2. Global Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chronic Urinary Retention
- Postoperative Urinary Retention
- Neurogenic Bladder
- 6.3. Global Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Transdermal
- 6.4. Global Urinary Retention Drug Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End Users
- 6.5. Global Urinary Retention Drug Market, Sub-Segmentation Of Alpha Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Alpha-1 Blockers
- Alpha-2 Blockers
- 6.6. Global Urinary Retention Drug Market, Sub-Segmentation Of Beta-3 Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Selective Beta-3 Agonists
- 6.7. Global Urinary Retention Drug Market, Sub-Segmentation Of Anticholinergics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antimuscarinics
- Non-Selective Anticholinergics
- 6.8. Global Urinary Retention Drug Market, Sub-Segmentation Of Surgical Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anesthetics
- Hemostatic Agents
- Muscle Relaxants
- Antibiotic Prophylaxis
- 7. Urinary Retention Drug Market Regional And Country Analysis
- 7.1. Global Urinary Retention Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Urinary Retention Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Urinary Retention Drug Market
- 8.1. Asia-Pacific Urinary Retention Drug Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Urinary Retention Drug Market
- 9.1. China Urinary Retention Drug Market Overview
- 9.2. China Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Urinary Retention Drug Market
- 10.1. India Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Urinary Retention Drug Market
- 11.1. Japan Urinary Retention Drug Market Overview
- 11.2. Japan Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Urinary Retention Drug Market
- 12.1. Australia Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Urinary Retention Drug Market
- 13.1. Indonesia Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Urinary Retention Drug Market
- 14.1. South Korea Urinary Retention Drug Market Overview
- 14.2. South Korea Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Urinary Retention Drug Market
- 15.1. Western Europe Urinary Retention Drug Market Overview
- 15.2. Western Europe Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Urinary Retention Drug Market
- 16.1. UK Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Urinary Retention Drug Market
- 17.1. Germany Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Urinary Retention Drug Market
- 18.1. France Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Urinary Retention Drug Market
- 19.1. Italy Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Urinary Retention Drug Market
- 20.1. Spain Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Urinary Retention Drug Market
- 21.1. Eastern Europe Urinary Retention Drug Market Overview
- 21.2. Eastern Europe Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Urinary Retention Drug Market
- 22.1. Russia Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Urinary Retention Drug Market
- 23.1. North America Urinary Retention Drug Market Overview
- 23.2. North America Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Urinary Retention Drug Market
- 24.1. USA Urinary Retention Drug Market Overview
- 24.2. USA Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Urinary Retention Drug Market
- 25.1. Canada Urinary Retention Drug Market Overview
- 25.2. Canada Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Urinary Retention Drug Market
- 26.1. South America Urinary Retention Drug Market Overview
- 26.2. South America Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Urinary Retention Drug Market
- 27.1. Brazil Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Urinary Retention Drug Market
- 28.1. Middle East Urinary Retention Drug Market Overview
- 28.2. Middle East Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Urinary Retention Drug Market
- 29.1. Africa Urinary Retention Drug Market Overview
- 29.2. Africa Urinary Retention Drug Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Urinary Retention Drug Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Urinary Retention Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Urinary Retention Drug Market Competitive Landscape And Company Profiles
- 30.1. Urinary Retention Drug Market Competitive Landscape
- 30.2. Urinary Retention Drug Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 31. Urinary Retention Drug Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb Company
- 31.2. AstraZeneca PLC
- 31.3. Novartis International AG
- 31.4. GlaxoSmithKline plc
- 31.5. Medtronic plc
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Eli Lilly and Company
- 31.8. Teva Pharmaceutical Industries Limited
- 31.9. Boehringer Ingelheim International GmbH
- 31.10. Astellas Pharma Inc.
- 31.11. Sun Pharmaceutical Industries Limited
- 31.12. Aurobindo Pharma Limited
- 31.13. Lupin Limited
- 31.14. Cadila Healthcare Limited
- 31.15. Torrent Pharmaceuticals Limited
- 32. Global Urinary Retention Drug Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Urinary Retention Drug Market
- 34. Recent Developments In The Urinary Retention Drug Market
- 35. Urinary Retention Drug Market High Potential Countries, Segments and Strategies
- 35.1 Urinary Retention Drug Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Urinary Retention Drug Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Urinary Retention Drug Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.